March 31, 2026 · Form 4 insider transaction
Soteropoulos Paula sold 599 shares of Dianthus Therapeutics, Inc. at $80.11 per share, a transaction worth $48.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.